We asked Dr. Lonial if we would continue to have Jimmy tested every two months, and he said we would. When Jimmy relapses, we want to catch it as quickly as possible.
Dr. Lonial was excited about their recent successes in treating patients with relapsed/refractory multiple myeloma with a new monoclonal antibody combined with lenalidomide. The response rate with this combination is quite high, with the ultimate goal of beating myeloma.
All this research and development is a strong international collaborative effort between Emory and their French myeloma colleagues, and the global trials are being led by Dr. Lonial's team at The Winship Cancer Institute at Emory.
.bmp)
No comments:
Post a Comment